Baker McKenzie FenXun's Greater China healthcare and life sciences group comprises lawyers who are medical practitioners, as well as lawyers who hold PhDs in molecular biology, biotechnology, pharmacology and bioethics. The practice, which additionally fields non-lawyer medical experts, acts for large pharmaceutical, medical device, healthcare and life sciences companies on both inbound and outbound work, including transactional, regulatory and compliance matters. Simon Hui leads the dispute resolution team in Shanghai; and at the firm’s joint operation partner, FenXun Partners, Vivian Wu leads the firm's investigations, compliance and ethics team in Beijing, where Yilan Yang specialises in the healthcare and cosmetics sectors. Over in Hong Kong, Isabella Liu, Derek Poon, Grace Tso and Mini vandePol are the names to note.
Key clients
- Hefei Tianhui Biotechnology Co
- Sino Biopharmaceutical
- Prenetics Global
- Sandoz
Work highlights
- Advised Hefei Tianhui Biotechnology Co on its joint venture collaboration with Oramed Pharmaceuticals and Oramed in the US.
- Assisted Sino Biopharmaceutical with entering into an alliance cooperation agreement, in relation to the clinical development and commercialisation of pharmaceutical products in mainland China with Boehringer Ingelheim.
- Advised Prenetics Global, a health sciences company, on the creation of a $200m joint venture with renowned scientist Professor Dennis Lo.
Practice head
The lawyer(s) leading their teams.
Isabella Liu, Robert Wright, Simon Hui, Derek Poon, Grace Tso, Mini vandePol, Vivian Wu